focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHRM.L Regulatory News (PHRM)

  • There is currently no data for PHRM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Advisory Board Appointment - Juan Villalonga

6 Jan 2011 07:05

RNS Number : 9859Y
Phorm Inc
05 January 2011
 



Phorm, Inc.

Advisory Board Appointment

6 January 2011

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO THE

UNITED STATES, CANADA, JAPAN OR AUSTRALIA

 

Phorm, Inc.

('Phorm' or the 'Company')

 

Advisory Board Appointment - Juan Villalonga

 

Phorm (AIM: PHRM and PHRX), the internet personalisation technology company, is pleased to announce the creation of an Advisory Board whose mandate will be to advise the board and management team on major aspects of the Company's business, in particular the adoption and deployment of the Company's technology with ISPs around the world.

 

The Company is also delighted to announce the appointment of Juan Villalonga as Chairman of the Company's Advisory Board. Further appointments will be made in due course.

 

As CEO of Telefónica S.A. from 1996-2000, Mr Villalonga oversaw an increase in the company's market capitalisation of $127 billion, in the process turning Telefónica into one of the top three telecommunications companies in the world.

 

Kent Ertugrul, Phorm's CEO said, "Juan Villalonga is a giant of the Telecommunications industry and we are delighted to welcome someone of his stature as Chairman of our Advisory Board. Following our successful launch in Brazil we have seen a significant increase in the level of interest from ISPs around the world and we look forward to working with Mr Villalonga to help us exploit these opportunities as we move to the next stage in our development."

 

Juan Villalonga has held a number of prominent positions in his career. In addition to his position within Telefónica S.A., he was a partner at McKinsey & Company (1980-1989), CEO for Credit Suisse First Boston in Spain (1993-1994), and CEO of Bankers' Trust in Spain (1995-1996). In 2010, Harvard Business Review named Mr. Villalonga one of the world's 100 best performing CEOs.

 

Juan Villalonga commented, "I am deeply impressed by the Company's team and technology. I believe that Phorm's proposition to consumers and the industry alike reflects the next stage in the evolution of the internet. By offering consumers an explicit choice and protecting the privacy of participants to an unprecedented degree, Phorm has managed to address one of the industry's big problems and provide a business model to support the next generation of internet services."

 

Enquiries:

 

Phorm, Inc.

Andy Croxson (analysts & investors) +44 20 7297 2326

Alex Laity (media) +44 20 7297 2710

 

Canaccord Genuity Limited +44 20 7050 6500

(Nominated Advisor)

Mark Williams

Andrew Chubb

 

About Phorm:

Phorm is a global personalisation technology company that makes content and advertising more relevant to the consumer. Phorm's innovative platform preserves user privacy and delivers a more interesting online experience. Phorm's partners include leading ISPs, Publishers, Ad Networks and Advertisers.

 

Phorm is a Delaware, US incorporated company, with offices in Seoul, Moscow, Sao Paulo and London. The Company was admitted to the AIM market of the London Stock Exchange in 2004 and has over 150 employees and direct contractors. For more information, please visit: www.phorm.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSSEFWIFFSEFF
Date   Source Headline
26th Mar 20145:00 pmRNSIntention to raise £10 million
10th Mar 20147:01 amRNSMemorandum of Understanding with China Telecom
27th Jan 20147:00 amRNSCommercial Launch in China
20th Jan 20147:00 amRNSChange of Adviser
17th Jan 20147:00 amRNSAIM Rule 17 Disclosure Schedule Two (g) Update
6th Jan 20147:00 amRNSExercise of Employee Warrants for Shares
19th Nov 20137:00 amRNSOperational Update for Phorm China
19th Nov 20137:00 amRNSEquity Placing to raise £10 million
13th Nov 20137:12 amRNSStmnt re Share Price Movement
24th Oct 201311:16 amRNSOperations Update
3rd Oct 20137:00 amRNSOperational Launch in China
30th Sep 20137:00 amRNSInterim Results
27th Sep 20137:00 amRNSOperations Update
28th Aug 201312:43 pmRNSAGM Statement
7th Aug 201310:52 amRNSStmnt re Share Price Movement
6th Aug 20137:00 amRNSAGM Statement
26th Jul 20137:00 amRNSTR1: Notification of major interest in shares
26th Jul 20137:00 amRNSTR1: Notification of major interest in shares
17th Jul 20139:20 amRNSIssue of Equity
28th Jun 20137:20 amRNSAnnual Report and Financial Statements
28th Jun 20137:20 amRNSTurkish Operations Update
29th May 20137:00 amRNSFinancing Update
8th May 20138:34 amRNSHolding(s) in Company
23rd Apr 201310:18 amRNSPlacing to raise £7.15 million
21st Mar 20133:20 pmRNSStatement re Share Price Movement
20th Mar 20137:00 amRNSFinancing Update
24th Jan 20137:00 amRNSChinese and Turkish Operations Update
4th Jan 20137:00 amRNSIssue of Shares
18th Dec 20127:00 amRNSIssue of Shares
17th Dec 20127:00 amRNSTurkish Operational Update
13th Dec 20127:00 amRNSTR1: Notification of major interest in shares
21st Nov 201212:33 pmRNSResult of EGM & Admission to trading
6th Nov 201211:50 amRNS£6m Placing, Contract Signature & Turkey Update
16th Oct 20127:00 amRNSCommercial Progress Update
28th Sep 20127:00 amRNSInterim Results
20th Sep 20127:00 amRNSUpdate on Turkey and Phorm China Equity Fundraise
11th Sep 20127:00 amRNSAdmission to Trading
10th Sep 20123:33 pmRNSSch 1 Update - Phorm Corporation Limited
7th Sep 20122:58 pmRNSResults of EGM - Correction
7th Sep 201212:29 pmRNSResults of EGM
5th Sep 20124:15 pmRNSNotification of Major Interests in Shares
31st Aug 20123:49 pmRNSUpdated Appendix to Schedule 1
13th Aug 20129:06 amRNSSchedule 1 - Phorm Corporation Limited
13th Aug 20127:00 amRNSPhorm Re-Domicile of Holding Company from Delaware
2nd Aug 20127:00 amRNSPlacing
9th Jul 20127:00 amRNSCommencement of Commercial Activities with TTNET
3rd Jul 201210:14 amRNSTransfer of Shares
29th Jun 20127:00 amRNSAnnual Financial Report
19th Jun 20126:01 pmRNSCorrection: AGM Result
19th Jun 201211:29 amRNSAGM Result

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.